InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,713.60
(
0.18%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
83.21
(
1.00%
)
Bitcoin
62,784.84
(
2.18%
)
Post# of 3683
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Reyeton

Send PM Follow Ignore
Followers 20
Posts 1232
Boards Moderated 0
Alias Born 04/13/2013

Reyeton

Re: None

Sunday, 04/05/2020 7:11:19 PM

Sunday, April 05, 2020 7:11:19 PM

Post# of 3683
MultiStem is a prime candidate for Right to Try in Coronavirus treatment, IMO. Here are the results of recently completed Phase 2 clinical trial:

https://www.athersys.com/clinical-trials/ards/
Athersys, Inc. - Clinical Trials - Acute Respiratory Distress Syndrome (ARDS)
www.athersys.com
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!